News

Lupin’s Goa facility inspection concluded by US FDA without any observations

By
Posted on

Lupin

Pharma major Lupin Limited (Lupin) announced today the successful completion of a PAI inspection (Prior Approval Inspection) carried out by the US FDA at its Goa manufacturing facility without any observations. The inspection which started on Monday, July 17th concluded today afternoon. 

 

Related Items:, ,

Recommended for you

Most Popular

20.7K
News

Sudden Cardiac Arrest More Dangerous Than Heart Attack; Awareness Abysmally Low

9.8K
Interviews

Sleep Apnea is likely to Lead to Health Issues

8.7K
News

Indian Industries Association launches cost-effective health insurance scheme for MSMEs

8.4K
Health Business

Zydus Cadila acquires US based Sentynl Therapeutics

8.4K
Interviews

Therapeutic Conversation, Helps in Respecting Patient Right to Health Information and Right to Compassionate Care

8.3K
News

SRL Diagnostics releases 4 year long data analysis report for antenatal testing

8.3K
News

Govt inks MoU to set up 1,000 ‘Janaushadhi Kendras’

8.2K
Policy Matter

Health Ministry Notifies Medical Devices Rules, 2017

7.5K
m-health

AddressHealth with Rs.10 crore series funding reaches out to counsel healthcare and mental wellness in schools

7.3K
News

Dr. Reddy’s Laboratories Ltd. Receives FDA approval for ZEMBRACETM SymTouch Injection

To Top
CXOTV Health